Michael Arenberg

Chief Operating Officer at IMAGO BIOSCIENCES, INC.

56 year

Health Technology

Consumer Services

Profile

Michael H.
Arenberg was the founder of IntraEAR, Inc. founded in 1996, where he held the title of VP-Sales, Marketing & Business Development from 1996 to 1999.
Currently, he is the Chief Operating & Business Officer at Imago BioSciences, Inc. since 2022.
Previously, he worked at DURECT Corp.
from 1999 to 2022, where he held the title of Senior VP-Corporate & Business Development from 2012 to 2018.
Mr. Arenberg has a graduate degree from the University of Denver and an MBA from Leavey School of Business.

Michael Arenberg active positions

Companies	Position	Start
IMAGO BIOSCIENCES, INC.	Chief Operating Officer	23/03/2022

All active positions of Michael Arenberg

Former positions of Michael Arenberg

Companies	Position	End
DURECT	Director of Finance/CFO	17/03/2022
IntraEAR, Inc. IntraEAR, Inc. Medical SpecialtiesHealth Technology Develops drug delivery devices for inner-ear maladies	Founder	01/01/1999

See the detail of Michael Arenberg's experience

Training of Michael Arenberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Arenberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
DURECT Corp. DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases	Health Technology
IntraEAR, Inc. IntraEAR, Inc. Medical SpecialtiesHealth Technology Develops drug delivery devices for inner-ear maladies	Health Technology
University of Denver University of Denver Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Leavey School of Business Leavey School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Imago BioSciences, Inc. Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases	Health Technology